VSTM (Verastem) Shiller PE Ratio: (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VSTM Verastem Inc VSTM
13 GF Score
Price $6.67
! 6 Warning Signs
View Full Analysis

What is Verastem Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Verastem  (NAS:VSTM) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Verastem Shiller PE Ratio Related Terms


Verastem Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Verastem's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Verastem Shiller PE Ratio Chart

Verastem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Verastem Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

VSTM vs PRME, ALT, FDMT: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Verastem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verastem Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verastem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Verastem's Shiller PE Ratio falls into.


VSTM
13GF Score
Verastem Inc VSTM
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Verastem Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Verastem's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Verastem's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.35/333.9520*333.9520
=-0.350

Current CPI (Jun. 2026) = 333.9520.

Verastem Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -2.520 241.428 -3.486
201612 -3.840 241.432 -5.312
201703 -4.200 243.801 -5.753
201706 -4.320 244.955 -5.890
201709 -7.320 246.819 -9.904
201712 -5.160 246.524 -6.990
201803 -4.920 249.554 -6.584
201806 -3.600 251.989 -4.771
201809 -3.480 252.439 -4.604
201812 -4.560 251.233 -6.061
201903 -6.240 254.202 -8.198
201906 -6.840 256.143 -8.918
201909 -4.920 256.759 -6.399
201912 -6.120 256.974 -7.953
202003 -4.200 258.115 -5.434
202006 -1.680 257.797 -2.176
202009 0.960 260.280 1.232
202012 -1.440 260.474 -1.846
202103 -1.080 264.877 -1.362
202106 -1.200 271.696 -1.475
202109 -1.560 274.310 -1.899
202112 -1.080 278.802 -1.294
202203 -1.080 287.504 -1.254
202206 -1.410 296.311 -1.589
202209 -1.100 296.808 -1.238
202212 -0.970 296.797 -1.091
202303 -0.940 301.836 -1.040
202306 -1.370 305.109 -1.500
202309 -0.750 307.789 -0.814
202312 -1.030 306.746 -1.121
202403 -1.260 312.332 -1.347
202406 -0.310 314.175 -0.330
202409 -0.600 315.301 -0.635
202412 -1.550 315.605 -1.640
202503 -0.960 319.799 -1.002
202506 -0.620 322.561 -0.642
202509 -1.350 324.800 -1.388
202512 -0.290 324.054 -0.299
202603 -0.460 330.213 -0.465
202606 -0.350 333.952 -0.350

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Verastem Business Description

Other Exchanges 0LOV:UK2VS:Germany
Address 117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
13GF Score

Get the complete analysis for VSTM

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.67
Price